Clinical Pharmacokinetics
Overview
Clinical Pharmacokinetics is a peer-reviewed journal that focuses on the study of drug absorption, distribution, metabolism, and excretion in humans. It provides comprehensive coverage of pharmacokinetic principles, methods, and applications, aiding in the optimization of drug therapy and the understanding of drug interactions, individual variability, and therapeutic drug monitoring.
Details
Details
Abbr.
Clin Pharmacokinet
Start
1976
End
Continuing
Frequency
Twelve no. a year, 2005-
p-ISSN
0312-5963
e-ISSN
1179-1926
Country
Switzerland
Language
English
Specialty
Pharmacology
Metrics
Metrics
h-index / Ranks: 881
184
SJR / Ranks: 3132
1125
CiteScore / Ranks: 1367
10.20
JIF / Ranks: 1882
4.5
Recent Articles
1.
2.
Mouton J, De Clercq A, De Paepe P, Petrovic M, Desmet T, Bruggemann R, et al.
Clin Pharmacokinet
. 2025 Mar;
PMID: 40064832
Background And Objective: Teicoplanin is a glycopeptide antibiotic used to treat severe Gram-positive infections. This systematic review provides a comprehensive overview of the current knowledge on the pharmacokinetics of teicoplanin...
3.
Li Q, Huang S, Zhang D, Zhang W, Mao Y, Chen R, et al.
Clin Pharmacokinet
. 2025 Mar;
PMID: 40048121
Aim: The aim of this study was to evaluate the safety, tolerability, and pharmacokinetics of single escalating oral doses of DDCI-01 (a novel, highly selective, long-acting phosphodiesterase type 5 inhibitor)...
4.
Kicken M, Deenen M, van der Wekken A, van den Borne B, van den Heuvel M, Ter Heine R
Clin Pharmacokinet
. 2025 Mar;
PMID: 40045151
Precision dosing of classical cytotoxic drugs in oncology remains underdeveloped, especially in treating non-small cell lung cancer (NSCLC). Despite advancements in targeted therapy and immunotherapy, classical cytotoxic agents continue to...
5.
Dermota T, Jug B, Trontelj J, Bozic Mijovski M
Clin Pharmacokinet
. 2025 Mar;
PMID: 40029501
Aims: The primary objective of this study was to determine whether concomitant therapy with ticagrelor and rosuvastatin affects rosuvastatin plasma concentrations in patients receiving rosuvastatin 40 mg/day after myocardial infarction....
6.
Beaucage-Charron J, Rinfret J, Trottier G, Sevigny M, Burry L, Marsot A, et al.
Clin Pharmacokinet
. 2025 Mar;
PMID: 40025366
Introduction: Pharmacokinetics (PKs) of drugs are often altered in the intensive care unit (ICU). Opioids are often used in the ICU, particularly as continuous infusions, and their characteristics lead them...
7.
Morales Junior R, Hambrick H, Mizuno T, Pavia K, Paice K, Tang P, et al.
Clin Pharmacokinet
. 2025 Feb;
PMID: 39988706
Background And Objective: This study aimed to develop a population pharmacokinetic model for cefepime in critically ill pediatric and young adult patients to inform dosing recommendations and to evaluate the...
8.
Otto M, van der Heijden K, Schoones J, van Esdonk M, Borghans L, Jacobs G, et al.
Clin Pharmacokinet
. 2025 Feb;
PMID: 39982684
No abstract available.
9.
Lou Y, Xu Y, Xiong Y, Deng C, Wang Q
Clin Pharmacokinet
. 2025 Feb;
PMID: 39961992
Background And Objectives: Efsubaglutide alfa is a novel long-acting human glucagon-like peptide-1 receptor agonist. Clinical studies in patients with type 2 diabetes (T2D) have shown excellent glucose-lowering effects. This study...
10.
Menichelli D, Pannunzio A, Baldacci E, Cammisotto V, Castellani V, Mormile R, et al.
Clin Pharmacokinet
. 2025 Feb;
PMID: 39937335
Background: Atrial fibrillation (AF) has multiple cardio-metabolic comorbidities, including obesity. The use of direct oral anticoagulants (DOACs) in patients with AF and obesity is still uncertain owing to the concern...